Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. (VTYX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VTYX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
3
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Ventyx Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
VTYX insider buying and selling by quarter
VTYX insider selling · VTYX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · VTYX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VTYX executive sell shares · VTYX board member insider trading · VTYX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 4, 2026 | Gonzales Roy Senior VP, Finance | Other | 5,313 | $74K | Form 4 |
| Mar 4, 2026 | Subramaniam Somu Director | Other | 3,337,495 | $46.72M⚡ | Form 4 |
| Mar 4, 2026 | GUJRATHI SHEILA Director | Other | 130,000 | $1.82M⚡ | Form 4 |
| Mar 4, 2026 | Nuss John CHIEF SCIENTIFIC OFFICER | Other | 489,481 | $6.85M⚡ | Form 4 |
| Mar 4, 2026 | Mohan Raju CEO AND PRESIDENT · Director | Other | 2,372,863 | $33.22M⚡ | Form 4 |
| Mar 4, 2026 | Forman Mark S Chief Medical Officer | Other | 6,000 | $84K | Form 4 |
| Feb 27, 2026 | Subramaniam Somu Director | Other | 694,718 | — | Form 4 |
| Dec 17, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Option | 116,668 | — | Form 4 |
| Dec 18, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Sale | 47,345 | $365K | Form 4 |
| Dec 17, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 34,930 | — | Form 4 |
| Dec 18, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 12,675 | $98K | Form 4 |
| Nov 17, 2025 | Forman Mark S Chief Medical Officer | Award | 3,000 | $3K | Form 4 |
| Nov 17, 2025 | Gonzales Roy Senior VP, Finance | Award | 1,767 | $2K | Form 4 |
| May 15, 2025 | Gonzales Roy Senior VP, Finance | Award | 1,750 | $2K | Form 4 |
| May 15, 2025 | Forman Mark S Chief Medical Officer | Award | 3,000 | $3K | Form 4 |
| Apr 2, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 1,887 | $2K | Form 4 |
| Mar 28, 2025 | Mohan Raju CEO AND PRESIDENT · Director | Option | 11,844 | — | Form 4 |
| Mar 28, 2025 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 4,531 | — | Form 4 |
| Mar 28, 2025 | Subramaniam Somu Director | Other | 1,335,450 | — | Form 4 |
| Mar 10, 2025 | Subramaniam Somu Director | Other | 1,735,306 | — | Form 4 |
| Dec 27, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 21,119 | $50K | Form 4 |
| Dec 23, 2024 | Gujrathi Sheila Director | Purchase | 130,000 | $301K | Form 4 |
| Dec 17, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Option | 34,930 | — | Form 4 |
| Dec 19, 2024 | Nuss John CHIEF SCIENTIFIC OFFICER | Sale | 13,161 | $30K | Form 4 |
| Dec 17, 2024 | Mohan Raju CEO AND PRESIDENT · Director | Option | 116,668 | — | Form 4 |
Subramaniam Somu
Director
Date
Mar 4
Shares
3,337,495
Price
$14.00
Value
$46.72M ⚡
Nuss John
CHIEF SCIENTIFIC OFFICER
Date
Mar 4
Shares
489,481
Price
$14.00
Value
$6.85M ⚡
Mohan Raju
CEO AND PRESIDENT · Director
Date
Mar 4
Shares
2,372,863
Price
$14.00
Value
$33.22M ⚡
Forman Mark S
Chief Medical Officer
Date
Mar 4
Shares
6,000
Price
$14.00
Value
$84K
Mohan Raju
CEO AND PRESIDENT · Director
Date
Dec 17
Shares
116,668
Price
—
Value
—
Mohan Raju
CEO AND PRESIDENT · Director
Date
Dec 18
Shares
47,345
Price
$7.72
Value
$365K
Nuss John
CHIEF SCIENTIFIC OFFICER
Date
Dec 18
Shares
12,675
Price
$7.72
Value
$98K
Forman Mark S
Chief Medical Officer
Date
Nov 17
Shares
3,000
Price
$1.03
Value
$3K
Forman Mark S
Chief Medical Officer
Date
May 15
Shares
3,000
Price
$1.03
Value
$3K
Mohan Raju
CEO AND PRESIDENT · Director
Date
Mar 28
Shares
11,844
Price
—
Value
—
Nuss John
CHIEF SCIENTIFIC OFFICER
Date
Dec 27
Shares
21,119
Price
$2.36
Value
$50K
Nuss John
CHIEF SCIENTIFIC OFFICER
Date
Dec 19
Shares
13,161
Price
$2.26
Value
$30K
Mohan Raju
CEO AND PRESIDENT · Director
Date
Dec 17
Shares
116,668
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VTYX insider trading
VTYX insider trades
Ventyx Biosciences, Inc. (VTYX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Nuss John (CHIEF SCIENTIFIC OFFICER), Mohan Raju (CEO AND PRESIDENT · Director), Gonzales Roy (Senior VP, Finance). Over the past 12 months, 5 insiders have filed transactions with the SEC. VTYX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ventyx Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VTYX insider trading · 5 questionsThe insiders of Ventyx Biosciences, Inc. (VTYX) include executives and directors such as Nuss John (CHIEF SCIENTIFIC OFFICER), Mohan Raju (CEO AND PRESIDENT · Director), Gonzales Roy (Senior VP, Finance), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026